IU Health Blood and Bone Marrow Stem Cell

Overview

The adult program is one of the leading centers for transplantation of patients with testicular/germ cell tumors. Clinical interests include immunotherapy and use of novel agents for treating patients with lymphoma and multiple myeloma. Research interests include haploidentical transplantation, adult cord blood transplantation, enhancement of post-transplant immune function, and graft vs host disease prevention and treatment. The pediatric program is the only stem cell transplant program in Indiana for children. Children treated include those with leukemia, solid tumors, immundeficiencies, sickle cell disease, other non-malignant conditions and rare genetic disorders. Research interests include graft vs. host disease and use of mesenchymal stromal cells for Fanconi Anemia. The Adult and Pediatric Programs are the first in Indiana to be certified to administer commercial CART-cell Therapy.

This center has been performing allogeneic transplants since 1985 and has been an NMDP transplant center since January 1988.

Attending physicians

Adult - Rafat Abonour, Varun Mittal, Michael Robertson, Jennifer Schwartz
Pediatric - W. Scott Goebel, Mirian Kim, April Rahrig, Kent Robertson, Jodi Skiles

Transplants performed

Marrow/PBSC, single cord, and double cord

Cord blood transplants

Adult and pediatric

Patient survival information for this center

This center's actual 1-year survival results are below the expected rate for this center*.

The survival information we have for this center includes ONLY:

Patients who had their FIRST ALLOGENEIC transplant (cells from a related or unrelated donor/cord blood) during 2020, 2021, 2022 and
Who had their transplant at a U.S. transplant center, and
Who had follow-up information provided by the transplant center for analysis

For this center, we have survival information for 224 patients.

The actual 1-year survival of these patients is 72.3%.

Compared to similar patients transplanted at all centers in the U.S., we expect that the 1-year survival for patients at this center to be in a range between 74.6% and 84.6%.

For help with understanding these statistics, please see Understanding Transplant Outcomes.

For overall survival for all patients transplanted with a specific disease, please see U.S. Patient Survival report

at bloodcell.transplant.hrsa.gov.

* The expected survival rate for a transplant center can be below, similar to, or above the range listed. This is based on comparing patient survival at all centers that treated patients with similar diseases.

The survival rate cannot tell how you will do with your transplant. Talk to your doctor to understand your prognosis or the likely course of your disease.

Total adult transplants

524

Transplants reported by the centers (from January 1, 2022 to December 31, 2023)

	Marrow	PBSC	Cord blood	Total
Allogeneic
Related donor	Marrow 1	PBSC 57	Cord blood 0	Total 58
Unrelated donor	Marrow 4	PBSC 82	Cord blood 0	Total 86
Total allogeneic	Marrow 5	PBSC 139	Cord blood 0	Total 144
Autologous	Marrow Both marrow & PBSC 380	PBSC —	Cord blood —	Total 380
Total combined	Marrow Both marrow & PBSC 524	PBSC —	Cord blood 0	Total 524

Total pediatric transplants

69

Transplants reported by the centers (from January 1, 2022 to December 31, 2023)

	Marrow	PBSC	Cord blood	Total
Allogeneic
Related donor	Marrow 18	PBSC 4	Cord blood 2	Total 24
Unrelated donor	Marrow 5	PBSC 3	Cord blood 3	Total 11
Total allogeneic	Marrow 23	PBSC 7	Cord blood 5	Total 35
Autologous	Marrow Both marrow & PBSC 34	PBSC —	Cord blood —	Total 34
Total combined	Marrow Both marrow & PBSC 64	PBSC —	Cord blood 5	Total 69

All Diseases

Number of transplants by age reported from January 1, 2022 to December 31st, 2023(includes marrow, PBSC and cord blood)

	0-18	19-44	45-64	65+	Total
Related	0-18 24	19-44 21	45-64 28	65+ 9	Total 82
Unrelated	0-18 11	19-44 18	45-64 42	65+ 26	Total 97
Autologous	0-18 35	19-44 118	45-64 157	65+ 104	Total 414
Total	0-18 70	19-44 157	45-64 227	65+ 139	Total 593

Treatments may be similar for diseases within a group. It might be helpful to look at centers that have done transplants for a specific disease and centers that have done transplants for any corresponding broad disease categories.

Centers are not required to report autologous transplants so the numbers might be incomplete.

More information about transplants can be found:

U.S. Transplant Data by Center (Opens in a new tab)
report at blood cell.transplant.hrsa.gov
List of diseases

Transplant center resources

Transplant center coordinator

Emily Ebelhar

Phone: 317-948-6476

Email: eebelhar@iuhealth.org

If you have questions about costs and financial services at this center, please call the transplant center’s direct phone number.

NMDP patient navigators

Patient navigators can answer your questions about choosing a transplant center and provide support and education to help you throughout your transplant journey.

Inside the United States: 1 (888) 999-6743
Outside the United States: 1 (763) 406-3410. (Long distance or international charges may apply.)

Email: patientinfo@nmdp.org

More resources

Choosing a transplant center
Preparing for transplant
Learn about transplant outcomes and treatment decisions (Opens in a new tab)
Support and resources (including non-English materials)
U.S. Transplant Data by Center (Opens in a new tab)
at blood cell.transplant.hrsa.gov

No survivorship program information is available. Contact the center for information about post-transplant care.